Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00002205
What this trial is testing

An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen

Who this might be right for
HIV Infections
Glaxo Wellcome
Not applicableStudy completedNCT00272220
What this trial is testing

Longitudinal Study of HAART, Social Networks, & Adherence

Who this might be right for
Acquired Immunodeficiency Syndrome
University of Washington 350
Post-approval studies (Phase 4)UnknownNCT06438146
What this trial is testing

LIROH - Liraglutide for Obesity in HIV

Who this might be right for
ObesityHIV Infections
Brigham and Women's Hospital 40
Early research (Phase 1)Study completedNCT02825797
What this trial is testing

3BNC117 and 10-1074 in HIV-infected Individuals

Who this might be right for
Human Immunodeficiency Virus (HIV)
Rockefeller University 34
Large-scale testing (Phase 3)Study completedNCT00279110
What this trial is testing

Directly Administered HIV Therapy in Methadone Clinics

Who this might be right for
HIV InfectionsHeroin Dependence
Johns Hopkins University 107
Large-scale testing (Phase 3)Study completedNCT00540449
What this trial is testing

TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.

Who this might be right for
HIV InfectionsHIV-1Human Immunodeficiency Virus Type 1
Tibotec Pharmaceuticals, Ireland 694
Large-scale testing (Phase 3)Study completedNCT00242840
What this trial is testing

Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 20
Early research (Phase 1)Not Yet RecruitingNCT06987318
What this trial is testing

Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection

Who this might be right for
HIV-1-infection
National Institute of Allergy and Infectious Diseases (NIAID) 40
Not applicableStudy completedNCT02918838
What this trial is testing

Supporting Adolescents to Adhere - an Intervention Using Airtime Rewards Allocated by a Prize Drawing

Who this might be right for
Human Immunodeficiency Virus
RAND 216
Early research (Phase 1)Study completedNCT00105417
What this trial is testing

Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral Treatment

Who this might be right for
HIV InfectionsHIV
National Institute of Allergy and Infectious Diseases (NIAID) 20
Early research (Phase 1)Study completedNCT03307915
What this trial is testing

2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Modified Vaccinia Ankara (MVA)-Mosaic OR Ad26.Mos4.HIV Plus a Combination of Mosaic and Clade C gp140 Protein in Human Immunodeficiency Virus (HIV) Type 1 Infected Adults on Suppressive Antiretroviral Treatment

Who this might be right for
Human Immunodeficiency Virus
Janssen Vaccines & Prevention B.V. 25
Early research (Phase 1)Study completedNCT00006320
What this trial is testing

Pharmacokinetics of Antiretroviral Agents in HIV-1 Infected Pregnant Women

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 20
Testing effectiveness (Phase 2)Looking for participantsNCT07030920
What this trial is testing

Reducing Systemic Inflammation in People on Antiretroviral Therapy

Who this might be right for
Human Immunodeficiency Virus (HIV)Cardiovascular Risk Factor
Centre hospitalier de l'Université de Montréal (CHUM) 150
Not applicableUnknownNCT03410680
What this trial is testing

A Habit-formation and Gamification Intervention to Improve ART Adherence Among MSM HIV Patients in Mexico

Who this might be right for
HIV
Instituto Nacional de Salud Publica, Mexico 184
Early research (Phase 1)Study completedNCT01982396
What this trial is testing

Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children

Who this might be right for
HIV Infection
PENTA Foundation 19
Post-approval studies (Phase 4)WithdrawnNCT02470650
What this trial is testing

Cost-effectiveness of Different Antiretroviral Treatment in Patients HIV Naive

Who this might be right for
Patient ComplianceAntiretroviral Therapy Intolerance
Juan A. Arnaiz
Large-scale testing (Phase 3)Study completedNCT01108510
What this trial is testing

Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Who this might be right for
HIVHIV Infections
Gilead Sciences 698
Early research (Phase 1)Study completedNCT00000902
What this trial is testing

A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 217
Post-approval studies (Phase 4)Study completedNCT00869700
What this trial is testing

Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-infected Adults

Who this might be right for
HIV InfectionsMalaria
University of Cape Town 18
Testing effectiveness (Phase 2)Study completedNCT01704781
What this trial is testing

Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART)

Who this might be right for
HIV-1 Infection
Bionor Immuno AS 36
Next Page